Peritoneal DialysisPeritoneal Dialysis, Continuous AmbulatorySurvival AnalysisPeritonitisSurvival RateKidney Failure, ChronicHemodialysis, HomeDialysis SolutionsAnuriaTreatment FailureProportional Hazards ModelsKaplan-Meier EstimateGlucansRetrospective StudiesTreatment OutcomeCell SurvivalTime FactorsPeritoneumFollow-Up StudiesSerum AlbuminProspective StudiesDisease-Free SurvivalPrognosisRenal DialysisCohort StudiesRisk FactorsCreatinineRegistriesSurvivalDiabetic NephropathiesNeoplasm StagingGraft SurvivalMultivariate AnalysisTumor Markers, BiologicalImmunohistochemistryBreast NeoplasmsPredictive Value of TestsAge FactorsNeoplasm Recurrence, LocalLife TablesDisease ProgressionLung NeoplasmsLymphatic MetastasisCombined Modality TherapyAdenocarcinomaAntineoplastic Combined Chemotherapy ProtocolsRecurrenceRisk AssessmentIncidenceTissue Array AnalysisLiver NeoplasmsBrain NeoplasmsChemotherapy, AdjuvantProsthesis FailureCarcinoma, Squamous CellCarcinomaNeoplasm GradingColorectal NeoplasmsNeoplasm MetastasisGene Expression Regulation, NeoplasticRegression AnalysisApoptosisReoperationAntineoplastic AgentsStomach NeoplasmsNeoplasm InvasivenessLongitudinal StudiesOvarian NeoplasmsCarcinoma, Non-Small-Cell LungSex FactorsModels, StatisticalUnited StatesSEER ProgramBiostatisticsNeoplasmsLongevityCause of DeathCell Line, TumorAnalysis of VarianceChi-Square DistributionProbabilityCarcinoma, HepatocellularKi-67 AntigenGlioblastomaRadiotherapy, AdjuvantAge of OnsetGene Expression ProfilingRiskMelanomaSeverity of Illness IndexActuarial AnalysisCannibalismSignal TransductionEsophageal NeoplasmsPostoperative ComplicationsMortalityMutationStrongylidaCell ProliferationCisplatin